|
|
||||||||
J Thorac Cardiovasc Surg 2009;138:1339-1348
© 2009 The American Association for Thoracic Surgery
Acquired Cardiovascular Disease |
a Division of Cardiology, Cliniques Universitaires, St-Luc, Université Catholique de Louvain, Brussels, Belgium
b Epidemiology and Biostatistics Unit, Université Catholique de Louvain, Brussels, Belgium
Received for publication May 19, 2008; revisions received February 27, 2009; accepted for publication March 29, 2009. * Address for reprints: Jean-Louis Vanoverschelde, MD, PhD, Division of Cardiology, Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10-2881, B-1200 Brussels, Belgium. (Email: vanoverschelde{at}card.ucl.ac.be).
Aims: The management of asymptomatic severe mitral regurgitation remains controversial. The aim of the study was to assess the long-term survival, incidence of cardiac complications, factors that predict outcome, and effect of mitral surgery on the long-term prognosis of patients with asymptomatic severe mitral regurgitation amenable to valve repair.
Methods: One hundred ninety-two asymptomatic patients (mean age, 63 ± 13 years) with severe degenerative mitral regurgitation diagnosed by 2-dimensional echocardiography between 1990 and 2001 were prospectively followed for a median of 8.5 years.
Results: Overall, cardiovascular, and event-free survival was evaluated in 2 groups of patients: a "conservative approach" group (n = 67) and an "early surgery" group (n = 125). Outcomes were also analyzed among patients with atrial fibrillation, pulmonary hypertension, or both, as well as in patients free of any mitral regurgitation complications. In the whole population, 10-year overall survival was significantly lower with the conservative approach than early surgery (50% ± 7% vs 86% ± 4%, log-rank < 0.0001). Similar results were obtained in the subgroups with atrial fibrillation and/or pulmonary hypertension. The 10-year propensity-matched score-adjusted hazards ratio for overall mortality, cardiac mortality, and cardiovascular events for the conservative treatment were 5.21, 4.83, and 4.40, respectively.
Conclusion: Our results show that the outcome of asymptomatic patients with severe degenerative mitral regurgitation is better with an early surgical approach rather than a more conservative treatment strategy.
This article has been cited by other articles:
![]() |
M. Ghoreishi, C. F. Evans, C. R. DeFilippi, G. Hobbs, C. A. Young, B. P. Griffith, and J. S. Gammie Pulmonary hypertension adversely affects short- and long-term survival after mitral valve operation for mitral regurgitation: Implications for timing of surgery J. Thorac. Cardiovasc. Surg., December 1, 2011; 142(6): 1439 - 1452. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Adams, J. Chikwe, F. Filsoufi, and A. C. Anyanwu The Year in Cardiovascular Surgery J. Am. Coll. Cardiol., March 29, 2011; 57(13): 1425 - 1444. [Full Text] [PDF] |
||||
![]() |
Z. Samad, P. Kaul, L. K. Shaw, D. D. Glower, E. J. Velazquez, P. S. Douglas, and J. G. Jollis Impact of early surgery on survival of patients with severe mitral regurgitation Heart, February 1, 2011; 97(3): 221 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Grigioni and A. Branzi Management of asymptomatic mitral regurgitation Heart, December 1, 2010; 96(23): 1938 - 1945. [Full Text] [PDF] |
||||
![]() |
D. H. Adams, R. Rosenhek, and V. Falk Degenerative mitral valve regurgitation: best practice revolution Eur. Heart J., August 2, 2010; 31(16): 1958 - 1966. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |